Your browser doesn't support javascript.
loading
Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis.
Gerstlauer, Michael; Szepfalusi, Zsolt; Golden, David; Geng, Bob; de Blic, Jacques.
Affiliation
  • Gerstlauer M; Pediatric Pneumology and Allergology unit, Medical University of Augsburg, Augsburg, Germany. Electronic address: Michael.Gerstlauer@uk-augsburg.de.
  • Szepfalusi Z; Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Golden D; Allergy & Immunology, Medstar Franklin Square Medical Center, Baltimore, Maryland.
  • Geng B; Divisions of Adult and Pediatric Allergy and Immunology, Rady Children's Hospital Severe Asthma Clinic, University of California, San Diego, California.
  • de Blic J; Pediatric Pneumology and Allergology unit, Necker-Enfants Malades Hospital, Paris, France; Université Paris Descartes, Paris, France.
Ann Allergy Asthma Immunol ; 123(1): 70-80, 2019 07.
Article in En | MEDLINE | ID: mdl-31009701
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pollen / Tablets / Conjunctivitis, Allergic / Poaceae Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pollen / Tablets / Conjunctivitis, Allergic / Poaceae Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2019 Type: Article